Lepodisiran
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lepodisiran, covering 2026-03-23 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) [Phase 3]